Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android:
Available for Mac and Windows Destops and laptops:
- Phototherapy trends in dermatology - light or dark? Correspondence to phototherapy trends in dermatology by Luersen et al. [JOURNAL ARTICLE]
- J Dermatolog Treat 2015 Jan 22.:1-2.
- Delusions of parasitosis; suggested dialogue between dermatologist and patient. [JOURNAL ARTICLE]
- J Dermatolog Treat 2015 Jan 20.:1-5.
- Self-reported quality of life after skin cancer in young adults. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Dec 30.:1-4.
- Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry. [JOURNAL ARTICLE]
- J Dermatolog Treat 2015 Jan 20.:1-7.
- Symptomatic dermatographism treated with narrowband UVB phototherapy. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Dec 29.:1-2.
- Treatment of 308nm Excimer Laser on Vitiligo: a Systemic Review of Randomized Controlled Trials. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Nov 27.:1-21.
Background:Vitiligo is an acquired cutaneous hypopigmentary disorder which characterized by solitary or multiple depigmented maculae or patches. The 308-nm excimer laser has been used as phototherapy on vitiligo.
Objective:To evaluate the efficacy and safety of 308-nm excimer laser on vitiligo.
Methods:Randomized Controlled Trials (RCTs) were searched to conduct a systematic review. The keywords were identified as laser/ excimer laser/ quasimolecule/ XeCl" and "vitiligo".
Results:Seven studies with 390 vitiligo patients were included. No significant differences were seen between 308-nm excimer laser and 308-nm excimer lamp on either ≥75% or ≥50% re-pigmentation rate, or between 308-nm excimer laser and narrow band-ultraviolet B (NB-UVB) on either 100% or ≥75% re-pigmentation rate. More patients or lesions achieved ≥50% re-pigmentation rate by 308-nm excimer laser treatment than by NB-UVB treatment. The side effects of 308-nm excimer laser were slight and tolerable.
Conclusions:The 308-nm excimer laser showed equivalent efficacies to 308-nm excimer lamp control and NB-UVB control concerning of ≥75% re-pigmentation rate of vitiligo patches. More studies with high methodological quality, low risk of bias and more sample size are needed to confirm the conclusion.
- Treatment Refusal Among Patients With Psoriasis. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Nov 27.:1-17.
Background.Treatment refusal, which is defined as a patient actively refusing to take treatment despite physician recommendations, has never been evaluated in psoriasis.
Objective.To investigate refusal of topical treatments by patients living with psoriasis in France.
Methods:Using responses to an internet study, participants who refused topical treatment (n = 50) were compared to those who applied topical treatment (n = 205). Participants undergoing phototherapy, biotherapy, and oral treatment were excluded. Spearman rank correlations completed by Fisher's exact tests and Student's t-tests were performed.
Results.Comorbidities, localization of lesions, and symptoms associated with psoriasis were not significant predictors of treatment refusal. Compared to patients who accepted treatment, more patients who refused treatment believed that psoriasis is not manageable (80.0% versus 61.5%; p=0.01), that psoriasis treatments never work (58.0% versus 27.5%; OR: 2.09 p<0.0001), and that all creams have the same effects (54.0% versus 31.7%; OR: 1.7, p=0.003). Among patients who reported seeking medical attention from physicians, more patients in the treatment refusal group reported some level of dissatisfaction with their relationship with their physician than in the treatment acceptance group. Limitations. The validity of the self-reported treatment refusal could not be evaluated.
Conclusion.Treatment refusal is an important element to be taken into consideration in the management of psoriasis.
- Polyphenols as novel treatment options for dermatological diseases: A systematic review of clinical trials. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Dec 30.:1-8.
- Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: A retrospective study. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Dec 29.:1-4.
- An Emerging Treatment: Topical Ivermectin for Papulopustular Rosacea. [JOURNAL ARTICLE]
- J Dermatolog Treat 2014 Nov 26.:1-8.